Abstract
Extramedullary (EM) involvement occurs infrequently in acute promyelocytic leukemia (APL) and usually involves skin and CNS. We describe seven patients (four observed at a single institution) who relapsed in various sites of the auditory apparatus, including the external canal and middle ear (temporal bone). Front-line treatment included ATRA and chemotherapy (six patients) or chemotherapy alone (one patient). Three patients had concomitant hematologic relapse, two had molecular relapse and two were in hematologic and molecular remission when ear localization was documented. Local symptoms that stimulated further diagnostic studies included ear bleeding/discharge in the first patient, but were mild in the others (hypoacusia, five patients; earache, two patients). Ear involvement by leukemia was documented by histological and/or molecular studies after local surgery in five cases, and by CT scan or NMR in the remaining patients. We suggest that the ear might represent a specific sanctuary for disease involvement in APL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chen S-J, Wang Z-Y, Chen Z . Acute promyelocytic leukemia: from clinic to molecular biology Stem Cells 1995 13: 22–31
Warrell RP Jr . Pathogenesis and management of acute promyelocytic leukemia Annu Rev Med 1996 47: 555–565
Fenaux P, Chomienne C, Degos L . Acute promyelocytic leukemia: biology and treatment Semin Oncol 1997 24: 92–102
Wang Z, Sun G, Shen Z, Chen S, Chen Z . Differentiation therapy for acute promyeloctyc leukemia with all-trans retinoid acid: 10-year experience of its application Chin Med 1999 112: 963–967
Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F . Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy Blood 1997 90: 1014–1021
Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH . All-trans retinoic acid in acute promyelocytic leukemia N Engl J Med 1997 337: 1201–1208
Estey E, Thall PF, Pierce S, Kantarjian H, Keating M . Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine J Clin Oncol 1997 15: 483–490
Soignet S, Fleischauer A, Polyak T, Heller G, Warrell RP Jr . All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study Cancer Chemother Pharmacol 1997 40 (Suppl.): S25–S29
Asou N, Adachi J, Tamura J, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama K, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake S, Suzushima H, Emi N, Ohno R . Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia teated with all-trans retinoic acid and chemotherapy J Clin Oncol 1998 16: 78–85
Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH for the MRC Adult Leukemia Working Party. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the randomized MRC trial Blood 1999 93: 4131–4143
Fenaux P, Chastang C, Chevret S, Sanz MA, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegnex N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L . A randomized comparison of ATRA followed by chemotherapy and ATRA plus chemotherapy, and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia Blood 1999 94: 1192–1200
Sanz MA, Martín G, Rayón C, Esteve J, Gonzalez M, Diaz-Mediavilla J, Bolufer P, Barragan E, Terol MJ, Gonzalez JD, Colomer D, Chillon C, Rivas C, Gomez T, Ribera JM, Bornstein R, Roman J, Calasanz MJ, Arias J, Alvarez C, Ramos F, Deben G . A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia Blood 1999 94: 3015–3021
Byrd JC, Edenfield WJ, Shields DJ, Dawson NA . Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review J Clin Oncol 1995 13: 1800–1816
Wiernik PH, De Bellis R, Muxi P, Dutcher JP . Extramedullary acute promyelocytic leukemia Cancer 1996 78: 2510–2514
Liso V, Specchia G, Pogliani EM, Palumbo G, Mininni D, Rossi V, Teruzzi E, Mestice A, Coppi MR, Biondi A . Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases Cancer 1998 83: 1522–1528
Ko B-S, Tang G-L, Chen Y-C, Yao M, Wang CH, Shen MC, Tien HF . Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia. The occurrence of retinoic acid syndrome is a risk factor Leukemia 1999 13: 1406–1408
Sanz M, Larrea L, Sanz GF, Martin G, Sempere A, Gomis F, Martinez J, Regerdera A, Saavedra S, Jarque I, Jimenez C, Cervera J, de la Rubia J . Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration A characteristic localization of chloromas in acute promyelocytic leukemia? Haematologica 2000 85: 758–762
Specchia G, Lo Coco F, Vignetti M, Avvisati G, Fazi P, Albano F, Di Raimondo F, Martino B, Ferrara F, Selleri C, Liso V, Mandelli F . Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with ATRA. A report by the Gimema group J Clin Oncol 2001 19: 4023–4028
Millot F, Klossec JM, Brizard F, Brizard A, Vandermarq P, Babin P, Giulhot F . Recurrence of childhood acute lymphoblastic leukemia presenting as a tumor of the middle ear: a case report J Ped Hematol 1997 19: 351–353
Tobita T, Shinjiyo K, Yanagi M, Takeshita A, Ohnishi K, Ohno R . Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid Intern Med 1997 36: 484–486
Kikuno K, Goto S, Iwasaki H, Saotome T, Takeshita A, Nagamura F, Watanabe J, Tsujimura H, Iseki T, Yonemitu H . Two patients with acute promyelocytic leukemia whose relapse was noted by cytodiagnosis of middle ear discharge Rinsho Ketsueki 1996 37: 323–328
Yagita M, Onishi R, Yamagata N, Shimazaki C, Kudoh H, Kobayashi M, Hikiji K, Konaka Y . Extramedullary relapse in the external auditory canal in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid and autologous peripheral blood stem cell trasplantation Rinsho Ketsueki 1998 39: 709–715
Goto H, Tsurumi H, Kasahara S, Hara T, Yamada T, Sawada M, Tanabashi S, Kametani M, Moriwaki H . Acute promyelocytic leukemia accompanied by scrotal Fournier's gangrene during ATRA treatment and relapsed as external ear tumor Rinsho Ketsueki 1998 39: 1169–1174
Au WY, Chan CF, Chim CS, Shek TW, Ooi GC, Ho WK, Kwong YL . External auditory canal tumor: a rare chloroma in acute promyelocytic leukemia with a complete response to arsenic trioxide J Clin Oncol 2001 20: 3993–3995
Lo Coco F, Diverio D, Falini B, Biondi A, Nervi C, Pelicci PG . Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia Blood 1999 94: 12–16
Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo Pardo C, Del Vecchio L . Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia Leukemia 1994 8 (Suppl. 2): S71–S76
Marchetti M, Falanga A, Giovanelli S, Oldani E, Barbui T . All-trans retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4 Br J Haematol 1996 93: 360–366
Brown DC, Tsui H, Larson RS . All-trans retinoic acid regulates adhesion mechanism and transmigration of the acute promyelocytic leukaemia cell line NB-4 under physiologic flow Br J Haematol 1999 107: 86–98
Murray CK, Estey E, Paietta E, Howard RS, Edenfield WJ, Pierce S, Mann KP, Bolan C, Byrd JC . CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome J Clin Oncol 1999 17: 293–297
Ferrara F, Morabito F, Martino B, Specchia G, Liso V, Nobile F, Boccuni P, Di Noto R, Pane F, Annunziata M, Schiavone EM, De Simone M, Guglielmi C, Del Vecchio L, Lo Coco F . CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans retinoic acid and chemotherapy J Clin Oncol 2000 18: 1295–1300
Acknowledgements
This work was supported by ROMAIL Associazione Italiana contro le Leucemie, Sezione di Roma, and AIRC (Associazione Italiana per la Ricerca sul Cancro).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Breccia, M., Petti, M., Testi, A. et al. Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated ‘sanctuary’?. Leukemia 16, 1127–1130 (2002). https://doi.org/10.1038/sj.leu.2402497
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402497
Keywords
This article is cited by
-
A case of acute promyelocytic leukemia variant with derivative chromosome 3 der(3)t(3;8) associated with 8q partial gain
Molecular Cytogenetics (2019)
-
Relapse of acute promyelocytic leukemia in the external auditory canal confirmed by PML/RARA dual-fusion and RARA break-apart fluorescence in situ hybridization
Annals of Hematology (2018)
-
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience
International Journal of Hematology (2009)
-
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
Leukemia (2006)
-
Acute promyelocytic leukemia and aural recurrence: the importance of otoscopy in early diagnosis
Leukemia (2003)